Judgment — ECLI:EU:T:2018:242
Date: 2018-05-03
Language of the case: English
Court formation: Sixth Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded
Origin: Austria

Action brought on 12 September 2016 — Gall Pharma v EUIPO — Pfizer (Styriagra) (Case T-662/16) Language in which the application was lodged: German Parties Applicant: Gall Pharma GmbH (Judenburg, Austria) (represented by: D. Reichelt and L. Figura, lawyers) Defendant: European Union Intellectual Property Office (EUIPO) Other party to the proceedings before the Board of Appeal: Pfizer Inc. (New York, New York, United States) Details of the proceedings before EUIPO Applicant for registration of the trade mark at issue: Applicant Trade mark at issue: EU word mark ‘Styriagra’ — EU trade mark application No 12 161 469 Proceedings before EUIPO: Opposition proceedings Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 June 2016 in Case R 724/2015-5 Form of order sought The applicant claims that the Court should: annul the contested decision and reject the opposition (Opposition Procedure No 002286568) to Community trade mark No 000233890; order the defendant to pay the costs. Pleas in law Infringement of Article 8(5) of Regulation No 207/2009; Infringement of Article 8(1)(b) of Regulation No 207/2009. ____________